Consensus report: clinical recommendations for the prevention and management of the nocebo effect in biosimilar-treated IBD patients - Université de Lorraine Access content directly
Journal Articles Alimentary Pharmacology & Therapeutics (Suppl) Year : 2019

Consensus report: clinical recommendations for the prevention and management of the nocebo effect in biosimilar-treated IBD patients

Ailsa Hart
  • Function : Author
  • PersonId : 887140

Abstract

The nocebo effect is a negative effect of a pharmacological or nonpharmacological medical treatment that is induced by patients' expectations, and that is unrelated to the physiological action of the treatment. The nocebo effect can negatively affect treatment outcomes.
No file

Dates and versions

hal-02923063 , version 1 (26-08-2020)

Identifiers

Cite

Lieven Pouillon, Silvio Danese, Ailsa Hart, Gionata Fiorino, Marjorie Argollo, et al.. Consensus report: clinical recommendations for the prevention and management of the nocebo effect in biosimilar-treated IBD patients. Alimentary Pharmacology & Therapeutics (Suppl), 2019, 49 (9), pp.1181-1187. ⟨10.1111/apt.15223⟩. ⟨hal-02923063⟩
48 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More